FAFTFSNP
TEVA icon

Fjarde AP-fonden (The Fourth Swedish National Pensionfund)’s Teva Pharmaceuticals TEVA Stock Holding History

Fjarde AP-fonden (The Fourth Swedish National Pensionfund)’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$5.04M Buy
+310,367
New +$4.78M 0.06% 317

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fjarde AP-fonden (The Fourth Swedish National Pensionfund)'s TEVA Position: Q2 2024 in Review

Fjarde AP-fonden (The Fourth Swedish National Pensionfund) opened a new position in Teva Pharmaceuticals (TEVA) in Q2 2024: 310,367 shares worth $5.04M. The stake represents 0.06% of the portfolio and ranks #317 among its holdings.

534 funds tracked by Wall St. Rank hold TEVA as of Q2 2024.

  • Fjarde AP-fonden (The Fourth Swedish National Pensionfund) held 310,367 shares of Teva Pharmaceuticals worth $5.04M as of Q2 2024.
  • Teva Pharmaceuticals was a new Fjarde AP-fonden (The Fourth Swedish National Pensionfund) position in Q2 2024.
  • Teva Pharmaceuticals made up 0.06% of Fjarde AP-fonden (The Fourth Swedish National Pensionfund)'s portfolio in Q2 2024, its #317 holding.
  • 534 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2024.

Based on Fjarde AP-fonden (The Fourth Swedish National Pensionfund)'s 13F filing for Q2 2024, filed 2 Aug 2024.